2010
DOI: 10.1016/j.jaut.2010.06.012
|View full text |Cite
|
Sign up to set email alerts
|

Activation of the type I interferon pathway in primary Sjogren’s syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
104
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 168 publications
(107 citation statements)
references
References 60 publications
(65 reference statements)
3
104
0
Order By: Relevance
“…IRF and TRIM21 expression in Sjögren's syndrome Sjö gren's syndrome is an autoimmune disease with increased levels of type 1 IFN and overexpression of type I IFN-stimulated genes, the so-called IFN signature (48)(49)(50). Using PBMCs from patients with a verified IFN signature, we found that TRIM21 is indeed expressed at higher levels compared with healthy controls (Fig.…”
Section: Irf4 and Irf8 Block The Irf1-mediated Induction Of Trim21 Exmentioning
confidence: 84%
“…IRF and TRIM21 expression in Sjögren's syndrome Sjö gren's syndrome is an autoimmune disease with increased levels of type 1 IFN and overexpression of type I IFN-stimulated genes, the so-called IFN signature (48)(49)(50). Using PBMCs from patients with a verified IFN signature, we found that TRIM21 is indeed expressed at higher levels compared with healthy controls (Fig.…”
Section: Irf4 and Irf8 Block The Irf1-mediated Induction Of Trim21 Exmentioning
confidence: 84%
“…The fact that the serum IFN bioactivity could be inhibited by neutralizing antibodies directed against IFN and IFN , provides evidence for a role of both type I IFNs in the induction of IFN type I response activity in RA (Mavragani et al, 2009). Upregulation of type I IFN-response genes has now been observed in peripheral blood cells and/or target tissues of (a subset of) patients with autoimmune diseases such as RA, SLE (Baechler et al 2005), SSc (Tan et al, 2006;Bos et al, 2009), SS (Mavragani & Crow, 2010), multiple sclerosis (Van Baarsen et al, 2006) and type 1 diabetes. These findings suggest that an activated IFN response gene expression program is a common denominator in chronic inflammatory diseases in general.…”
Section: A Type I Ifn Response Signature In the Peripheral Blood Of Amentioning
confidence: 99%
“…The etiology of Sjogren's syndrome remains unidentified (16). Interactions between environmental contributors such as viruses or stress in conjunction with genetic susceptibility factors and hormonal effects are currently believed to result in disease development (16,17).…”
Section: Aetiology and Pathogenesismentioning
confidence: 99%
“…Interactions between environmental contributors such as viruses or stress in conjunction with genetic susceptibility factors and hormonal effects are currently believed to result in disease development (16,17). Intrinsic activation of epithelium in various target organs was demonstrated (18), based on inappropriate expression of MHC molecules, overexpression of costimulatory molecules and capacity for cytokine production, and the term "autoimmune epithelitis" was proposed (19 (16,20) However, the mechanisms that account for the epithelial activation remain stil unclear (16). Recent data suggest the central role of the type I interferon (IFN) system in the pathogenesis of many autoimmune disorders including SS (16).…”
Section: Aetiology and Pathogenesismentioning
confidence: 99%